Results 61 to 70 of about 6,029 (168)
Self-controlled case series with multiple event types [PDF]
, 2017 Self-controlled case series methods for events that may be classified as one of several types are described. When the event is non-recurrent, the different types correspond to competing risks.
Douglas, Ian J. +4 more
core +1 more source
Musculoskeletal Diseases: Mechanisms and Therapeutic Advances
MedComm, Volume 6, Issue 12, December 2025.Musculoskeletal diseases comprise a broad spectrum of inflammatory, degenerative, and neoplastic disorders. Increasing evidence highlights the central role of immune regulation in their pathogenesis, with complex interactions among immune, bone, muscle, and stromal cells.
Xiao Ma +17 more
wiley +1 more source
What is the addiction risk associated with tramadol? [PDF]
, 2005 Tramadol (Ultram, generic and with acetaminophen in Ultracet) carries a risk of substance abuse (strength of recommendation [SOR]: B, based on case report surveillance programs).
Mackler, Leslie, McDiarmid, Todd
core
The Challenges of Vascular Implants: Regulatory Strategies and Biological Responses
Small Science, Volume 5, Issue 12, December 2025.Implantable vascular devices are revolutionizing the management of cardiovascular diseases, such as heart failure, by enabling real‐time monitoring and individualized therapy. However, their potential is challenged by regulatory constraints and biological barriers, as device implantation into a vessel can trigger inflammation, thrombosis, and long‐term
Serena Babboni +5 more
wiley +1 more source
Nelarabine Associated Myotoxicity and Rhabdomyolysis
Case Reports in Hematology, 2015 Nelarabine (ara-G; Arranon; compound 506U78) is an antineoplastic purine analog used for the treatment of refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).
Mahnur Haider +2 more
doaj +1 more source
Drug therapeutic failures as a cause of admission to an intensive care unit at a university hospital
Journal of Research in Pharmacy Practice, 2019 Objective: Drug therapeutic failures (TFs) are included in pharmacovigilance reporting, as some authors consider them a type of adverse drug reaction.
Jair Antonio Ruiz-Garzon +2 more
doaj +1 more source
Skin Research and Technology, Volume 31, Issue 12, December 2025.ABSTRACT Background Melanosis is an acquired hyperpigmentation disorder that can be associated with the use of medications; timely identification and discontinuation of relevant medications is an important aspect of clinical management. Objective This study investigates the relationship between melanosis and drug exposure based on data from the FDA ...
Yilin Zhao +3 more
wiley +1 more source
Post-Market Surveillance Study of a Skull Flap Fixation Device: Cranfixer
Iranian Journal of Neurosurgery, 2019 Background and Aim: Cranfixer was approved in 2017 by the Food and Drug Administration of Iran as a skull flap fixation and also a burr hole cover.
Seyed Roholah Ghodsi +3 more
doaj
Incentivizing the Utilization of Pharmacogenomics in Drug Development [PDF]
, 2012 Pharmacogenomics, the study and development of compounds according to how an individual’s genes affects the body’s response to drugs, holds enormous promise for increasing the safety and efficiency of drug development while decreasing adverse reactions ...
Koch, Valerie Gutmann
core +1 more source
Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction [PDF]
, 2014 Aims. We investigate the effect of glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors on long-term outcomes following percutaneous coronary intervention (PCI) after non-ST elevation myocardial infarction (NSTEMI). Meta-analyses indicate that these agents are
Antoniou, S +9 more
core +4 more sources